Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Josef von Rickenbach, who co-founded the company, will retire
March 5, 2018
By: Kristin Brooks
Managing Editor, Contract Pharma
Jamie Macdonald has been appointed chief executive officer of PAREXEL effective March 15, 2018. Josef von Rickenbach, who co-founded the company, will retire and continue as chairman of the board. Mr. Macdonald led INC Research, now Syneos Health, for several years first as chief executive officer and most recently as vice chairman. Under his leadership, INC Research achieved strong operational and market performance, and undertook a successful Initial Public Offering (IPO) in 2014. Prior to this, he served as INC’s chief operating officer. In addition, Mr. Macdonald has held several leadership positions in the biopharmaceutical services industry, including senior vice president and head of Global Project Management at Quintiles, now known as IQVIA. Mr. von Rickenbach co-founded PAREXEL in 1982 and has since served as chairman and chief executive officer, building the company to a valuation of over five billion dollars with operations in more than 100 countries. “When we started PAREXEL more than 35 years ago, not only was it the beginning of a new company, it was also the dawn of a new industry,” said Mr. von Rickenbach. “Today, a new era begins. The biopharmaceutical services industry is more dynamic and exciting than ever, and Jamie is the right leader to take PAREXEL into the future. I am confident that our next generation will be an even greater one and I am delighted to have him join the Company. I look forward to working with Jamie to continue PAREXEL’s leadership in the marketplace.” <!– /* Font Definitions */ @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:1; mso-generic-font-family:roman; mso-font-format:other; mso-font-pitch:variable; mso-font-signature:0 0 0 0 0 0;} @font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-536870145 1073786111 1 0 415 0;} /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0in; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi;} p {mso-style-noshow:yes; mso-style-priority:99; mso-margin-top-alt:auto; margin-right:0in; mso-margin-bottom-alt:auto; margin-left:0in; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin;} .MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi;} @page WordSection1 {size:8.5in 11.0in; margin:1.0in 1.0in 1.0in 1.0in; mso-header-margin:.5in; mso-footer-margin:.5in; mso-paper-source:0;} div.WordSection1 {page:WordSection1;} — <!–{cke_protected}{C}%3C!%2D%2D%0A%20%2F*%20Font%20Definitions%20*%2F%0A%40font-face%0A%09%7Bfont-family%3A%22Cambria%20Math%22%3B%0A%09panose-1%3A2%204%205%203%205%204%206%203%202%204%3B%0A%09mso-font-charset%3A1%3B%0A%09mso-generic-font-family%3Aroman%3B%0A%09mso-font-format%3Aother%3B%0A%09mso-font-pitch%3Avariable%3B%0A%09mso-font-signature%3A0%200%200%200%200%200%3B%7D%0A%40font-face%0A%09%7Bfont-family%3ACalibri%3B%0A%09panose-1%3A2%2015%205%202%202%202%204%203%202%204%3B%0A%09mso-font-charset%3A0%3B%0A%09mso-generic-font-family%3Aswiss%3B%0A%09mso-font-pitch%3Avariable%3B%0A%09mso-font-signature%3A-536870145%201073786111%201%200%20415%200%3B%7D%0A%20%2F*%20Style%20Definitions%20*%2F%0Ap.MsoNormal%2C%20li.MsoNormal%2C%20div.MsoNormal%0A%09%7Bmso-style-unhide%3Ano%3B%0A%09mso-style-qformat%3Ayes%3B%0A%09mso-style-parent%3A%22%22%3B%0A%09margin%3A0in%3B%0A%09margin-bottom%3A.0001pt%3B%0A%09mso-pagination%3Awidow-orphan%3B%0A%09font-size%3A12.0pt%3B%0A%09font-family%3A%22Calibri%22%2Csans-serif%3B%0A%09mso-ascii-font-family%3ACalibri%3B%0A%09mso-ascii-theme-font%3Aminor-latin%3B%0A%09mso-fareast-font-family%3ACalibri%3B%0A%09mso-fareast-theme-font%3Aminor-latin%3B%0A%09mso-hansi-font-family%3ACalibri%3B%0A%09mso-hansi-theme-font%3Aminor-latin%3B%0A%09mso-bidi-font-family%3A%22Times%20New%20Roman%22%3B%0A%09mso-bidi-theme-font%3Aminor-bidi%3B%7D%0Ap%0A%09%7Bmso-style-noshow%3Ayes%3B%0A%09mso-style-priority%3A99%3B%0A%09mso-margin-top-alt%3Aauto%3B%0A%09margin-right%3A0in%3B%0A%09mso-margin-bottom-alt%3Aauto%3B%0A%09margin-left%3A0in%3B%0A%09mso-pagination%3Awidow-orphan%3B%0A%09font-size%3A12.0pt%3B%0A%09font-family%3A%22Times%20New%20Roman%22%2Cserif%3B%0A%09mso-fareast-font-family%3ACalibri%3B%0A%09mso-fareast-theme-font%3Aminor-latin%3B%7D%0A.MsoChpDefault%0A%09%7Bmso-style-type%3Aexport-only%3B%0A%09mso-default-props%3Ayes%3B%0A%09font-family%3A%22Calibri%22%2Csans-serif%3B%0A%09mso-ascii-font-family%3ACalibri%3B%0A%09mso-ascii-theme-font%3Aminor-latin%3B%0A%09mso-fareast-font-family%3ACalibri%3B%0A%09mso-fareast-theme-font%3Aminor-latin%3B%0A%09mso-hansi-font-family%3ACalibri%3B%0A%09mso-hansi-theme-font%3Aminor-latin%3B%0A%09mso-bidi-font-family%3A%22Times%20New%20Roman%22%3B%0A%09mso-bidi-theme-font%3Aminor-bidi%3B%7D%0A%40page%20WordSection1%0A%09%7Bsize%3A8.5in%2011.0in%3B%0A%09margin%3A1.0in%201.0in%201.0in%201.0in%3B%0A%09mso-header-margin%3A.5in%3B%0A%09mso-footer-margin%3A.5in%3B%0A%09mso-paper-source%3A0%3B%7D%0Adiv.WordSection1%0A%09%7Bpage%3AWordSection1%3B%7D%0A%2D%2D%3E
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !